Zx (2 End)
Brimonidine Tartrate 0.25% / Ivermectin 1% / Metronidazole 1% / Niacinamide 4%
Product Images NDC 72934-1028
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate 0.25% / Ivermectin 1% / Metronidazole 1% / Niacinamide 4% (NDC 72934-1028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
C (1028 2 Front)
Ff (1028 2 Middle)
This appears to be a label for a medication that contains active ingredients Brimonidine Tartrate USP, Ivermectin USP, Metronidazole USP, and Niacinamide USP. The medication also contains inactive ingredients such as Potassium Azeloyl Diglycinate and Suspendisse Gel. The percentages of each ingredient are also provided. The medication name and its purpose are not provided, and it is not clear if the text is complete.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
